Cargando…
Nicotine has no significant cytoprotective activity against SARS-CoV-2 infection
When coronavirus disease 2019 (COVID-19) became a pandemic, one of most important questions was whether people who smoke are at more risk of COVID-19 infection. A number of clinical data have been reported in the literature so far, but controversy exists in the collection and interpretation of the d...
Autores principales: | Zheng, Fang, Lian, Elena, Ramirez, Gaby, McAlister, Carley, Zhou, Shuo, Zhang, Wen, Liu, Chunming, Perera, Rushika, Zhan, Chang-Guo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387791/ https://www.ncbi.nlm.nih.gov/pubmed/35980910 http://dx.doi.org/10.1371/journal.pone.0272941 |
Ejemplares similares
-
Development of SARS-CoV-2 Nucleocapsid Specific Monoclonal Antibodies
por: Terry, James S., et al.
Publicado: (2020) -
Development of a SARS-CoV-2 nucleocapsid specific monoclonal antibody
por: Terry, James S., et al.
Publicado: (2021) -
The 19th Rocky Mountain Virology Association Meeting
por: Rovnak, Joel, et al.
Publicado: (2020) -
The 20th Anniversary Meeting of the Rocky Mountain Virology Association
por: Rovnak, Joel, et al.
Publicado: (2020) -
Synthetic nicotine has arrived
por: Jordt, Sven-Eric
Publicado: (2023)